TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT05979974

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: High energy density pulse electromagnetic field
Description: The treatment coil is placed over the shoulder region at the maximum pain point for 9 minutes. A high energy of high-PEMF with a rate of 3 pulse per second is applied to the patient.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: physiotherapy
Description: Physiotherapy such as shoulder passive and active-assisted range of motion (ROM) exercises, Pendulum exercises, Codman's exercises and Cross-body reach exercises. Under the physiotherapist's guidance, the patient receives the training session about 30 minutes every time.

Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: physiotherapy
Description: Physiotherapy such as shoulder passive and active-assisted range of motion (ROM) exercises, Pendulum exercises, Codman's exercises and Cross-body reach exercises. Under the physiotherapist's guidance, the patient receives the training session about 30 minutes every time.

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: sham High energy density pulse electromagnetic field
Description: The sham treatment coil is placed over the shoulder region at the maximum pain point for 9 minutes. The setting is the same as the experimental group(high energy, a rate of 3 pulse per second) with the difference that the energy output doesn't export to the patient.
Study: NCT06289192

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: C-Raven Virtual Tobacco Cessation Counseling
Description: A two-module tobacco cessation intervention that involves interaction with a virtual counselor and includes instruction about addiction and the use of pharmacotherapy for cessation. Each module takes approximately 20 minutes to complete.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nicotine Replacement Product
Description: Participants will be offered a 12-week supply of nicotine patches and either nicotine gum or lozenges.
Study: NCT06582134

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: BMBI
Description: Participants are requested to listen to the recordings 3 times a week, for 3 months (in a standardized sequence e.g. A-B-C and repeat) on Mondays-Wednesdays-Fridays. They are instructed to listen right before they sleep and encouraged to use them whenever they feel stressed or in pain.
Study: NCT05984888

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: MIND Diet Intervention Group
Description: Participants will receive individually tailored nutrition counseling on adopting the MIND diet pattern from a registered dietitian nutritionist (RDN) for a total of 8 sessions spanning 12 weeks. After completing the counseling sessions participants will be followed up 6 months later to collect additional questionnaires and assessments.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: General Health Curriculum (GHC) Group
Description: Participants will meet with trained study staff for 8 sessions spanning 12 weeks covering content on non-diet related health topics. After these sessions, participants will be followed up 6 months later to collect additional questionnaires and assessments. Once 6-month follow-up has been completed, participants will be offered to receive the MIND diet intervention offered in the MIND Diet Intervention Group.
Study: NCT04707261

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dapagliflozin
Description: Participants will receive dapagliflozin 10 mg once daily

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Participants will receive placebo 10 mg once daily
Study: NCT06289192

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Community Health Worker
Description: A community health worker will meet with each participant throughout the study period to teach appropriate NRT usage, discuss barriers/facilitators to NRT use and cessation, conduct shared decision-making about lung cancer screening, and provide health system navigation when needed.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Lung Cancer Screening
Description: Eligible participants will be referred to their primary care physician or existing specialist to complete lung cancer screening.
Study: NCT06026462

Intervention type: DIAGNOSTIC_TEST
Intervention: Observation of clinical indicators related to asthma
Description: Observe the severity of asthma, drug compliance, comorbidities, asthma control, pulmonary function, FeNO, and the number of acute episodes of asthma

Intervention type: DIAGNOSTIC_TEST
Intervention: Observation of clinical indicators related to asthma
Description: Observe the severity of asthma, drug compliance, comorbidities, asthma control, pulmonary function, FeNO, and the number of acute episodes of asthma
Study: NCT06636175

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 64Cu-LLP2A
Description: 64Cu-LLP2A, will be manufactured following batch production record at the cyclotron GMP facility (Washington University School of Medicine GMP radiochemistry/cyclotron facility)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 64Cu-LLP2A
Description: 64Cu-LLP2A, will be manufactured following batch production record at the cyclotron GMP facility (Washington University School of Medicine GMP radiochemistry/cyclotron facility)
Study: NCT06414967

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Music Intervention
Description: Music therapy carried out with Music Care
Study: NCT06636175

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: PET/CT
Description: The results of 64Cu-LLP2A-PET/CT will not be provided to the patient or the treating oncologist/surgeon unless, in the judgment of the principal investigator, the images demonstrate an unsuspected abnormality that may warrant further evaluation.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: PET/CT
Description: The results of 64Cu-LLP2A-PET/CT will not be provided to the patient or the treating oncologist/surgeon unless, in the judgment of the principal investigator, the images demonstrate an unsuspected abnormality that may warrant further evaluation.
Study: NCT06436846

Intervention type: OTHER
Intervention: Biospecimen sample collection during standard-of-care surgery
Description: Patients in this observational study are undergoing planned surgical resection of their retroperitoneal sarcoma as prescribed by their primary surgeon and treatment team. In addition to removal of the primary tumor, surgeons remove 4 samples of retroperitoneal fat and a sample of subcutaneous fat for further study at the time of the operation.
Study: NCT06484998

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Dental anxiety level and child's compomer colors selection
Description: Patients without any syndromes or systemic disorders, without mental retardation, who needed restorative treatment for primary molars were included in the study. The examination forms of 275 patients requiring restorative treatment of primary teeth were analysed at the session they came for restorative treatment. To determine the child's anxiety, the Modified Child Dental Anxiety Scale-faces version was administered to the children before restorative treatment. The children were asked to choose from a scale consisting of 9 colours (pink, blue, gold, silver, orange, yellow, green, purple, white) for the compomer restoration color selections. The patients were asked what their favourite color was after the compomer restoration color selection so that the previous question would not have any effect on the child's restoration color selection.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Dental anxiety level and child's compomer colors selection
Description: Patients without any syndromes or systemic disorders, without mental retardation, who needed restorative treatment for primary molars were included in the study. The examination forms of 275 patients requiring restorative treatment of primary teeth were analysed at the session they came for restorative treatment. To determine the child's anxiety, the Modified Child Dental Anxiety Scale-faces version was administered to the children before restorative treatment. The children were asked to choose from a scale consisting of 9 colours (pink, blue, gold, silver, orange, yellow, green, purple, white) for the compomer restoration color selections. The patients were asked what their favourite color was after the compomer restoration color selection so that the previous question would not have any effect on the child's restoration color selection.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Dental anxiety level and child's compomer colors selection
Description: Patients without any syndromes or systemic disorders, without mental retardation, who needed restorative treatment for primary molars were included in the study. The examination forms of 275 patients requiring restorative treatment of primary teeth were analysed at the session they came for restorative treatment. To determine the child's anxiety, the Modified Child Dental Anxiety Scale-faces version was administered to the children before restorative treatment. The children were asked to choose from a scale consisting of 9 colours (pink, blue, gold, silver, orange, yellow, green, purple, white) for the compomer restoration color selections. The patients were asked what their favourite color was after the compomer restoration color selection so that the previous question would not have any effect on the child's restoration color selection.
Study: NCT05350033

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: tDCS - tDCS
Description: active-tDCS administered during 10 sessions, in Phase 1 and Phase 2

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: tDCS - Sham
Description: active-tDCS administered during 5 sessions, in Phase 1
Study: NCT05346653

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: SGLT2i
Description: dapagliflozin (10 mg daily)

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: No SGLT2i
Description: No SGLT2i
Study: NCT06551259

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Description: Intravenous infusion of 0.6μg/kg load dose of dexmedetomidine within 10 minutes after intubation, followed by continuous infusion at a rate of 0.4 μg/kg/h until 30 minutes before the end of surgery

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: physiological saline
Description: physiological saline
Study: NCT05763771

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Smart Phone App
Description: Collection of data

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Smart Phone App
Description: Collection of data

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: NIcotine Patches
Description: Place on the skin

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: NIcotine Patches
Description: Place on the skin
Study: NCT05013125

Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: ENDO-AID CADe assisted Colonoscopy
Description: ENDO-AID is a dedicated endoscopy Computer-Aided Diagnosis (CADe) system where suspicious lesions are automatically detected and highlighted on the main monitor in real-time, alerting the endoscopist during the procedure.
Study: NCT05350033

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Sham - tDCS
Description: active-tDCS administered during 5 sessions, in Phase 2

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham - Sham
Description: sham-tDCS administered during 10 sessions, in Phase 1 and Phase 2
Study: NCT04768426

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Capecitabine
Description: 1000 mg/m2 administered on Days 1 to 14 of 21-day treatment cycles, for 8 cycles.
Study: NCT06427850

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tranexamic acid
Description: receive an injection of Tranexamic acid into the surgical site

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Normal saline
Description: receive an injection of Normal saline into the surgical site
Study: NCT05257681

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Interlobar fissure completion and pleural adhesiolysis
Description: A video-assisted thoracic surgery or robotic approach will be used to perform pleural adhesiolysis and the lobar fissure adjacent to the previously targeted lobe during bronchoscopic lung volume reduction will be completed using a surgical stapler.
Study: NCT05820126

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Cold-stored platelet concentrate
Description: Patients will be transfused a unit of pooled, pathogen reduced platelets that have been stored for \>24 hours at 1-6˚C

Intervention type: BIOLOGICAL
Group type: OTHER
Intervention: Cold-stored platelet concentrate
Description: Patients will be transfused a unit of pooled, pathogen reduced platelets that have been stored for \>24 hours at 1-6˚C
Study: NCT06158919

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fruquintinib、Nivolumab、Sintilimab、Oxaliplatin、Teysuno、Capecitabine
Description: Combined treatment period: A total of 6 cycles of combined treatment Fruquintinib: 4 mg/d, qd po, d1-14, q3w. Nivolumab: 360mg iv.gtt d1, q3w or Sintilimab: 200mg iv.gtt d1, q3w SOX : Oxaliplatin 130mg/m2 iv.gtt d1, Teysuno 40mg/m2 p.o.b.i.d. d1\~ 14q3w. Or XELOX regimen: oxaliplatin 130mg/m2 iv.gtt d1 Capecitabine 1000mg/m2 p.o. b.i.d. d1\~ 14q3w.~Maintenance treatment period:~Fruquintinib: 4 mg/d, qd po, d1-14, q3w. Nivolumab: 360mg iv.gtt d1, q3w or Sintilimab: 200mg iv.gtt d1, q3w Teysuno 40mg/m2 p.o.b.i.d. d1\~14 q3w or Capecitabine 1000mg/m2 p.o.b.i.d. d1\~14 q3w.~Maintenance of treatment until disease progression or toxicity becomes intolerable.
Study: NCT04718454

Intervention type: DEVICE
Intervention: dental attachment
Description: This research aimed to evaluate the retentive power and wear of the smart box attachment use with tilted two implant assisted mandibular overdenture

Intervention type: DEVICE
Intervention: dental attachment
Description: This research aimed to evaluate the retentive power and wear of the smart box attachment use with tilted two implant assisted mandibular overdenture
Study: NCT06582329

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Alfa1 Antitrypsin
Description: Participants will be treated intravenously with A1AT 120 mg/kg bodyweight once a week for 4 weeks (4 total infusions).
Study: NCT06113835

Intervention type: PROCEDURE
Intervention: CTO PCI
Description: percutaneous coronary intervention
Study: NCT06131957

Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Fluoride varnish with SBGC
Description: The Fluoride varnish (containing 5% NaF, Duraphat®, Colgate-Palmolive Company, NY, USA) mixed with 7.5% SBGC (Dencare (Chongqing) Oral Care Co., Ltd).
Study: NCT06131957

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Fluoride varnish
Description: The Fluoride varnish (containing 5% NaF, Duraphat®, Colgate-Palmolive Company, NY, USA)
Study: NCT06583486

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Rcombinant botulinum neurotoxin type A for injection (YY001)
Description: Five sites will be injected at 0.05 mL each, 2 sites in corrugator muscle of each side and 1 site in the procerus muscle, for a total dose of 20U.
Study: NCT06297421

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Fecal Microbiota Transplantation
Description: Oral Fecal Microbiota Transplantation Capsule

Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Oral Placebo Capsule
Study: NCT05488093

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: X-sens sensor
Description: the procedure will include:~* 7 to 8 sensors (Foot, leg, thigh, pelvis and chest possibly).~* 5 movements/exercises for the patients, each exercise performed 3 times except walking~* Analysis of 20m walking cycle (normal speed, most natural arm movement, 4 return trips of 20m):~* Climbing up and down stairs (using the public stairs of the rheumatology access department, 6 steps of 20 cm height, at normal speed, without using the handrail)~* Getting up from a chair without the help of hands (start standing, then the patient sits, leans and stands up, feet together, without taking the feet off the floor, using one and the same chair for each patient with a height of 50 cm)
Study: NCT05462418

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: electrosurgery
Description: incisions completed using use the unipolar diathermy from Whiteline till we reach the parietal peritoneum (cutting the Whiteline then coagulation till reaching the peritoneum). The used diathermy frequency was 50-70 MHz.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: scalpel
Description: patients had their incisions completed using the surgical scalpel till we reach the parietal peritoneum.
Study: NCT05039710

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: JNJ-75220795
Description: JNJ-75220795 will be administered as SC injection.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: JNJ-75220795
Description: JNJ-75220795 will be administered as SC injection.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Matching placebo will be administered as SC injection.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Matching placebo will be administered as SC injection.
Study: NCT05869864

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Schools Championing Safe South Africa
Description: The intervention consists of 2 parts - a poster campaign with social norms messages on violence and HIV risk, and 2 lessons in life orientation (a health curriculum delivered during school).
Study: NCT04736628

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Avenciguat
Description: Avenciguat

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Avenciguat
Description: Avenciguat

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Avenciguat
Description: Avenciguat

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo
Study: NCT06549660

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Active PBMT
Description: Active with a dose of 165 J per site, resulting in a total dose of 495J.

Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Placebo PBMT
Description: Placebo, without therapeutic dose.
Study: NCT05775731

Intervention type: DIAGNOSTIC_TEST
Intervention: Tests for markers of inflammation and activated hemostasis
Description: Volunteers who do not have exclusion criteria, are invited to complete the three questionnaires and to choose a date for blood drawing based on whether they are shift workers or not. Blood is immediately processed for platelet markers, and stored for inflammation and coagulation markers

Intervention type: DIAGNOSTIC_TEST
Intervention: Tests for markers of inflammation and activated hemostasis
Description: Volunteers who do not have exclusion criteria, are invited to complete the three questionnaires and to choose a date for blood drawing based on whether they are shift workers or not. Blood is immediately processed for platelet markers, and stored for inflammation and coagulation markers
Study: NCT06303219

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: RADITIONAL MODERATE INTENSITY TRAINING
Description: It consists of patients who will receive High-intensity interval training, including running as well as walking at 80% to 95% HR peak. Which is monitored by a smart watch. Before starting treatment, it follows a 10-minute warm-up exercise which includes basic stretches (Quads, Hams, and calf muscles) with a 30-second hold of both legs and same exercise will be pursued for the cool-down period. This intervention will be performed 5 days per week for 4 weeks.~The total duration of this session will be 50 minutes

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: HIGH INTENSITY INTERVAL TRAINING
Description: It consists of patients who will receive Moderate-intensity interval training, including running as well as walking at 60% HR peak. Which is monitored by a smart watch. Before starting treatment, it follows a 10-minute warm-up exercise which includes basic stretches (Quads, Hams, and calf muscles) with a 30-second hold of both legs and same exercise will be pursued for the cool-down period. This intervention will be performed 5 days per week for 4 weeks.~The total duration of this session will be 50 minutes (
Study: NCT06017791

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: tunnel technique with a 3D printed PEEK shell to fill the skeletal subnasal depression
Description: The area will be anesthetized using infiltration technique with 1.5ml of anesthetic solution containing Articaine Hydrochloride 68 mg/1.7 ml with Adrenaline 0.017 mg/1.7 ml~Two bilateral full thickness vertical incisions will be created using a #15 blade. One on each side of the frenum~A subperiosteal tunnel connecting the two vertical incisions will be created using a periosteal elevator/tunneling knife until the complete communication between the two ends is established~The custom made PEEK framework will be inserted from the incision on one side and eased through until it sits in the subnasal concavity.~Once fitted in place the shell will be fixed in place using two mini screws bilaterally, one on each side.~The two vertical incisions will be closed by interrupted sutures 6-0 Polyglycolic acid suture material
Study: NCT06303323

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Qigong Exercise
Description: Baduanjin Exercise will be performed which consists of 8 standing postures. At least 30 minutes per time. 10-13 min for a set of Badaunjin.~In the first 2 weeks, two sets of Baduanjin will be performed. Total Duration: 6 weeks Frequency: for 3 days/week. (alternative days) Intensity: low-intensity exercise Total Time: 50 Minutes Type: aerobic training

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Wu Dang Tai Chi
Description: Wu Dang 13 form postures will be performed. Initially, each posture will be performed 3 times then progressively increase to more according to the patient's discomfort.~Total Duration: 6 weeks Frequency: 3 times/ week (alternative day ) Intensity: Low to Moderate Intensity Time: 50 Minutes Type: aerobic training
Study: NCT06530771

Intervention type: DIAGNOSTIC_TEST
Intervention: ultrasound
Description: Conventional US, SWE, and AP of thyroid nodules were conducted successively with a Supersonic Aixplorer system (SuperSonic Imagine, Aix-en-Provence, France) using a 5-14 MHz linear transducer.

Intervention type: DIAGNOSTIC_TEST
Intervention: ultrasound
Description: Conventional US, SWE, and AP of thyroid nodules were conducted successively with a Supersonic Aixplorer system (SuperSonic Imagine, Aix-en-Provence, France) using a 5-14 MHz linear transducer.
Study: NCT04957368

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nitrous Oxide 99 %
Description: Nitrous oxide will be administered at an inspiratory concentration of 50% with concurrent intravenous saline (100ml) for one hour.
Study: NCT04728282

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: RTSA with subscapularis repair
Description: Lateralized reverse total shoulder arthroplasty with repair of subscapularis

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: RTSA without subscapularis repair
Description: Lateralized reverse total shoulder arthroplasty without repair of subscapularis